Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02471807 · ClinicalTrials.gov registry record · NA
Early Feasibility Study of the Edwards FORMA Tricuspid Transcatheter Repair System
A NA study, sponsored by Edwards Lifesciences.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT02471807 is a NA study that has completed, run by Edwards Lifesciences. The registered enrollment target is 34 participants.
The verdict
NCT02471807, a NA study, has completed, sponsored by Edwards Lifesciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
The study is a multi-center, prospective, early feasibility study to measure individual patient clinical outcomes and effectiveness, evaluate the safety and function, provide guidance for future clinical study designs and development efforts of the Edwards FORMA Tricuspid Transcatheter Repair System.
Interventions
- DEVICE Edwards FORMA Tricuspid Transcatheter Repair System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2015-12 |
| Est. Completion | 2023-01-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02471807
The ClinicalTrials.gov registry entry for NCT02471807 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Edwards Lifesciences, which has 57 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Edwards FORMA Tricuspid Transcatheter Repair System is the first listed.
NCT02471807 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02471807 about?
NCT02471807 is a clinical study titled "Early Feasibility Study of the Edwards FORMA Tricuspid Transcatheter Repair System". The study is a multi-center, prospective, early feasibility study to measure individual patient clinical outcomes and effectiveness, evaluate the safety and function, provide guidance for future clinical study designs and development efforts of the Edwards FORMA Tricuspid Transcatheter Repair System...
What is the current status of trial NCT02471807?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2015-12. Estimated completion is 2023-01-17.
What interventions are being tested in trial NCT02471807?
The interventions under investigation include: Edwards FORMA Tricuspid Transcatheter Repair System (DEVICE).
Who is sponsoring clinical trial NCT02471807?
This trial is sponsored by Edwards Lifesciences, which has 57 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.